万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>遗传学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>药学

MOLECULAR DIAGNOSIS & THERAPY《分子诊断与治疗》 (官网投稿)

简介
  • 期刊简称MOL DIAGN THER
  • 参考译名《分子诊断与治疗》
  • 核心类别 SCIE(2023版), 目次收录(知网),外文期刊,
  • IF影响因子
  • 自引率0.60%
  • 主要研究方向医学-GENETICS & HEREDITY遗传学;PHARMACOLOGY & PHARMACY药学

主要研究方向:

等待设置主要研究方向
医学-GENETICS & HEREDITY遗传学;PHARMACOLOGY & PHARMACY药学

MOLECULAR DIAGNOSIS & THERAPY《分子诊断与治疗》(双月刊). Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into&n...[显示全部]
征稿信息

万维提示:

1、投稿方式:官网投稿。

2、期刊网址:

https://www.springer.com/journal/40291

3、投稿网址:

https://www.editorialmanager.com/mdta/default1.aspx

4、期刊刊期:双月刊,逢单月出版,一年出版6期。

          20220111日星期二

                     

 

投稿须知【官网信息】

                      

MOLECULAR DIAGNOSIS & THERAPY

Instructions for Authors

Please read these instructions in conjunction with the "Additional Information for Authors" document. This document, together with other useful submission documentation, can be found by following the "Important Information for Authors" link:

Important Information for Authors

Types of Papers

Please note:

The word counts given below do not include the abstract, references, figure legends or table captions.

Leading Article. Word count up to 4000. Provides a short, balanced overview of the current state of development of an emerging area.

Review Article. Word count 3000 to 6000. Provides an authoritative, balanced, comprehensive, fully referenced and critical review of the literature.

Current Opinion. Word count 1500 to 4000. Places an area in perspective given that it is of current international interest and a consensus has not yet been reached; therefore, the arguments presented may be controversial, but at the same time must be balanced and rational.

Systematic Review. Word count up to 10,000. Collates all empirical evidence that fits pre-specified eligibility criteria to answer a specific research question. It uses explicit, systematic methods that are selected with a view to minimizing bias, thus providing reliable findings from which conclusions can be drawn and decisions made. Please follow the reporting guidelines of PRISMA.

Original Research. The journal will consider studies with a genetic focus, such clinical trials (particularly well-designed, randomised studies), meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies. Such papers should be submitted as Original Research Articles, following the reporting guidelines of CONSORT for randomized controlled trials and STROBE for purely observational studies. Reports of studies that have investigated original approaches to clinical management but that are smaller in scale and, thus, may report pilot data warranting further investigation, may also be considered for publication; such articles should be submitted as Short Communications.

Letter to the Editor. Word count up to 1000. Comment on an article published recently in the journal; a response to the comments would normally be sought from the authors of the original article and published in the same issue, where possible.

Editorial/Commentary. Word count up to 1500. A brief opinion piece on a current topic of high interest.

Editorial Procedure

Internal Review by Editorial Staff: The journal editor will perform an initial appraisal of each manuscript. If your paper has been peer reviewed by another journal as part of a prior submission, the journal editor will also assess any previous editorial/referee comments and how these have been dealt with as part of the appraisal process. If your manuscript is considered unsuitable for the journal to which it has been submitted, it may be assessed for suitability for publication in other Adis journals by appropriate editors. However, it will not be progressed to external peer review for an alternative journal without your permission.

External Peer Review: Peer reviewer identities are kept confidential, but author identities are known to the reviewers. Peer reviewers are asked to disclose potential conflicts of interests that may affect their ability to provide an unbiased review of an article. The majority of manuscripts will require some degree of revision following peer review before they can be accepted for publication. The final decision on acceptability for publication lies with the journal editor.

Copy Editing: All accepted manuscripts are copy edited. This process addresses general publishing considerations, such as layout of tables and figures, housestyle and clarity of expression. Authors will receive proofs following editing for their approval and sign off. It should be noted that the responsibility for checking the technical accuracy and consistency of data within the article rests with the authors

Manuscript Submission

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities tacitly or explicitly at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission

Please follow the hyperlink Submit manuscript on the right and upload all of your manuscript files following the instructions given on the screen.

Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.

Title Page

Please make sure your title page contains the following information.

Title

The title should be concise and informative.

……

更多详情:

https://www.springer.com/journal/40291/submission-guidelines


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭